Italia markets closed

BMY May 2025 38.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,88000,0000 (0,00%)
Alla chiusura: 03:33PM EDT
Schermo intero
Chiusura precedente1,8800
Aperto1,9400
Denaro1,6900
Lettera1,9700
Prezzo d'esercizio38,00
Scadenza2025-05-16
Min-Max giorno1,8800 - 1,9400
Contratto - Min-MaxN/D
Volume256
Open Interest692
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri